Aileron Therapeutics
Clinical-stage leader in the field of stapled peptide therapeutics for cancers and other diseases. Learn more
Launch date
Employees
Market cap
AUD91.7m
Enterprise valuation
AUD65m (Public information from Sep 2024)
Share price
$2.91 ALRN
Cambridge Massachusetts (HQ)
Authorizing premium user...